Article info
PDFClinical ethics
Paper
Assent as an ethical imperative in the treatment of ADHD
- Correspondence to Dr Anson J Koshy, Department of Pediatrics, Children's Learning Institute, The University of Texas Health Science Center at Houston, 6655 Travis Ste. 880, Houston, TX 77030, USA; anson.j.koshy{at}uth.tmc.edu
Citation
Assent as an ethical imperative in the treatment of ADHD
Publication history
- Received April 2, 2014
- Revised April 10, 2015
- Accepted June 10, 2015
- First published June 25, 2015.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- Causal modelling of variation in clinical practice and long-term outcomes of ADHD using Norwegian registry data: the ADHD controversy project
- Pharmacological and non-pharmacological treatment of adults with ADHD: a meta-review
- The effect of ADHD on the life of an individual, their family, and community from preschool to adult life
- Examining the pharmacological and psychological treatment of child and adolescent ADHD in Australia: Protocol for a retrospective cohort study using linked national registry data
- Prevalence, determinants and spectrum of attention-deficit hyperactivity disorder (ADHD) medication of children and adolescents in Germany: results of the German Health Interview and Examination Survey (KiGGS)
- Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006
- Prevalence of attention-deficit hyperactivity disorder in children, adolescents and adults in the Middle East and North Africa region: a systematic review and meta-analysis
- Comorbidities and functional impairments in children with attention deficit hyperactivity disorder in China: a hospital-based retrospective cross-sectional study
- Methylphenidate for ADHD rejected from the WHO Essential Medicines List due to uncertainties in benefit-harm profile
- Childhood attention-deficit/hyperactivity disorder